MedPath

Alexion Pharma GmbH

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

9

Active:9
Completed:0

Trial Phases

1 Phases

Phase 1:9

Drug Approvals

28

CANADA:14

Drug Approvals

VOYDEYA

Approval Date
Nov 7, 2024
CANADA

VOYDEYA

Approval Date
Nov 7, 2024
CANADA

ULTOMIRIS

Approval Date
Apr 19, 2023
CANADA

ULTOMIRIS

Approval Date
Apr 19, 2023
CANADA

KOSELUGO

Approval Date
Jan 3, 2023
CANADA

KOSELUGO

Approval Date
Jan 3, 2023
CANADA

ULTOMIRIS

Approval Date
Sep 9, 2021
CANADA

KANUMA

Approval Date
Apr 5, 2018
CANADA

STRENSIQ

Approval Date
Jun 7, 2016
CANADA

STRENSIQ

Approval Date
Jun 1, 2016
CANADA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials

Phase 1
9 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.